OPS
JANX icon

Orion Portfolio Solutions’s Janux Therapeutics JANX Stock Holding History

Orion Portfolio Solutions’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,913
Closed -$263K – 1933
2024
Q4 		$263K Sell
4,913
-1,692
-26% -$89.5K ﹤0.01% 1616
2024
Q3 		$300K Sell
6,605
-1,202
-15% -$52.3K ﹤0.01% 1520
2024
Q2 		$327K Sell
7,807
-3,153
-29% -$148K ﹤0.01% 1433
2024
Q1 		$413K Buy
+10,960
New +$239K ﹤0.01% 1350

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Orion Portfolio Solutions's JANX Position: Q1 2025 in Review

Orion Portfolio Solutions sold out of Janux Therapeutics (JANX) in Q1 2025, closing a stake of 4,913 shares — an estimated $263K sold.

Orion Portfolio Solutions first reported a position in JANX in Q1 2024 and held it in 4 quarters. The position peaked at $413K in Q1 2024. 181 funds tracked by Wall St. Rank hold JANX as of Q1 2025.

  • Orion Portfolio Solutions reported no remaining Janux Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Orion Portfolio Solutions sold 4,913 Janux Therapeutics shares in Q1 2025, an estimated $263K.
  • Orion Portfolio Solutions first reported a position in Janux Therapeutics in Q1 2024 and held it in 4 quarters.
  • Orion Portfolio Solutions's Janux Therapeutics position peaked at $413K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.